Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
CVS says 2024 Medicare Advantage enrollment exceeds expectations
06:57am, Friday, 05'th Jan 2024
CVS Health said on Friday enrollment for 2024 in some of its Medicare Advantage plans, through which it provides health insurance for people aged 65 and older, exceeded its expectations.
CVS names interim CFO Tom Cowhey as permanent finance chief
06:39am, Friday, 05'th Jan 2024
CVS Health Corp. CVS, -0.46% said Friday it has appointed Tom Cowhey, currently senior vice president of corporate finance and interim chief financial officer as its permanent CFO. The drug store chai
Here's Why CVS Health (CVS) Fell More Than Broader Market
06:48pm, Thursday, 04'th Jan 2024
CVS Health (CVS) closed the most recent trading day at $80.51, moving -0.46% from the previous trading session.
CVS Pharmacy Launches Simplified, Two-Tiered Loyalty Program
05:32pm, Thursday, 04'th Jan 2024
CVS Pharmacy, the retail division of CVS Health, simplified its loyalty program by consolidating it into one membership with two tiers. With both tiers of the ExtraCare program, CVS Pharmacy will offe
AbbVie shares higher following ‘overdone' reaction to CVS move to replace top-selling arthritis drug
02:06pm, Thursday, 04'th Jan 2024
Abbvie Inc (NYSE:ABBV) shares recovered in the early afternoon Thursday after dipping 3% in after hours trade the evening prior on the news that CVS Health Corp (NYSE:CVS) announced it will remove Hu
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
10:33am, Thursday, 04'th Jan 2024
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Abbvie shares down as CVS moves to replace top selling arthritis drug with cheaper alternatives
03:22am, Thursday, 04'th Jan 2024
Abbvie Inc (NYSE:ABBV) shares fell after hours on Wednesday after CVS Health Corp announced it will remove Humira, a leading rheumatoid arthritis medication, from some preferred drug lists for reim
CVS Partially Dropping Top-Selling Drug Humira In Favor Of Cheaper Biosimilars
07:14pm, Wednesday, 03'rd Jan 2024
CVS Caremark, the pharmaceutical subsidiary of CVS Health, announced Wednesday it will replace AbbVie's Humira from its list of covered drugs with cheaper alternatives for some customers—a move that
Abbvie shares tumble after CVS drops Humira in favor of biosimilars
05:38pm, Wednesday, 03'rd Jan 2024
CNBC's Bertha Coombs joins 'Fast Money' to talk Abbvie's stock sliding in extended trading after CVS announced it is dropping coverage of Humira.
CVS will remove AbbVie's Humira from some drug reimbursement lists in April
05:04pm, Wednesday, 03'rd Jan 2024
CVS Health said on Wednesday it will remove AbbVie's blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of April 1, and will recommend biosimil
CVS Health stock a top broker pick; faster earnings growth seen
01:26pm, Tuesday, 02'nd Jan 2024
CVS Health Corp (NYSE:CVS) has two things it didn't have during the past few years: a clear path to accelerating earnings growth; and appropriately reset expectations, according to Bank of America an
Here's Why You Should Retain CVS Health (CVS) Stock for Now
12:01pm, Wednesday, 27'th Dec 2023
Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan.
CVS Health (CVS) Surpasses Market Returns: Some Facts Worth Knowing
06:47pm, Thursday, 21'st Dec 2023
In the closing of the recent trading day, CVS Health (CVS) stood at $78.62, denoting a +1.79% change from the preceding trading day.
3 No-Brainer Stocks to Buy Right Now for Less than $100
05:50am, Thursday, 21'st Dec 2023
Brookfield Renewable is poised for strong long-term growth as the demand for renewable energy increases. CVS Health is a bargain with an attractive dividend.
Dividend Income Summary: Lanny's November 2023 Summary
04:00am, Thursday, 21'st Dec 2023
Dividend Income Summary: Lanny's November 2023 Summary
